Sera Prognostics, Inc.

As of June 18, 2025, the trend is mildly bearish, influenced by daily moving averages and weekly KST showing bearish momentum, despite some bullish signals from the weekly MACD.

Sera Prognostics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $0 million and a net loss of $8 million as of March 2025, with a market cap of $69.32 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -34.80%.

As of Jun 18, Sera Prognostics, Inc. has a market capitalization of 69.32 million, with net sales of 0.11 million and a net profit of -32.99 million over the latest four quarters. The company reported shareholder's funds of 47.80 million and total assets of 72.75 million as of Dec 24.